Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RIZATRIPTAN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mahuzier, PE; Clark, BJ; Crumpton, AJ; Altria, KD
      Quantitative microemulsion electrokinetic capillary chromatography analysis of formulated drug products

      JOURNAL OF SEPARATION SCIENCE
    2. Cull, R
      Almotriptan: a balanced approach to migraine

      HOSPITAL MEDICINE
    3. Diener, HC; McHarg, A
      Pharmacology and efficacy of eletriptan for the treatment of migraine attacks - Reply

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    4. Cipolla, G; Sacco, S; Crema, F; Moro, E; De Ponti, F; Frigo, G
      Gastric motor effects of triptans: Open questions and future perspectives

      PHARMACOLOGICAL RESEARCH
    5. Ma, QP
      Co-localization of 5-HT1B/1B/1F receptors and glutamate in trigeminal ganglia in rats

      NEUROREPORT
    6. Musson, DG; Birk, KL; Panebianco, DL; Gagliano, KD; Rogers, JD; Goldberg, MR
      Pharmacokinetics of rizatriptan in healthy elderly subjects

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    7. Gomez-Mancilla, B; Cutler, NR; Leibowitz, MT; Spierings, ELH; Klapper, JA; Diamond, S; Goldstein, J; Smith, T; Couch, JR; Fleishaker, J; Azie, N; Blunt, DE
      Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patientswith acute migraine

      CEPHALALGIA
    8. Ferrari, MD; Loder, E; McCarroll, KA; Lines, CR
      Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials

      CEPHALALGIA
    9. Meckling, SK; Becker, WJ; Rose, MS; Dalby, JT
      Sumatriptan responsiveness and clinical, psychiatric and psychologic features in migraine patients

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    10. Goldberg, MR; Sciberras, D; De Smet, M; Lowry, R; Tomasko, L; Lee, Y; Olah, TV; Zhao, J; Vyas, KP; Halpin, R; Kari, PH; James, I
      Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    11. Lines, CR; Vandormael, K; Malbecq, W
      A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients

      PAIN
    12. Adelman, JU; Adelman, RD
      Current options for the prevention and treatment of migraine

      CLINICAL THERAPEUTICS
    13. Solomon, S; Frishberg, B; Hu, XH; Markson, L; Berger, M
      Migraine treatment outcomes with rizatriptan in triptan-naive patients: A naturalistic study

      CLINICAL THERAPEUTICS
    14. Fuseau, E; Petricoul, O; Sabin, A; Pereira, A; O'Quinn, S; Thein, S; Leibowitz, M; Purdon, H; McNeal, S; Salonen, R; Metz, A
      Effect of encapsulation on absorption of sumatriptan tablets: Data from healthy volunteers and patients during a migraine

      CLINICAL THERAPEUTICS
    15. Ferrari, MD; Roon, KI; Lipton, RB; Goadsby, PJ
      Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials

      LANCET
    16. Tepper, SJ
      Safety and rational use of the triptans

      MEDICAL CLINICS OF NORTH AMERICA
    17. Newman, LC; Lipton, RB
      Migraine MLT-down: An unusual presentation of migraine in patients with aspartame-triggered headaches

      HEADACHE
    18. Loder, E; Brandes, JL; Silberstein, S; Skobieranda, F; Bohidar, N; Wang, LX; Boyle, D; Kolodny, A; Guerra, F; Santanello, N; Johnson-Pratt, L
      Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine

      HEADACHE
    19. Lipton, RB; Pascual, J; Goadsby, PJ; Massiou, H; McCarroll, KA; Vandormael, K; Jiang, KH; Lines, CR
      Effect of rizatriptan and other triptans on the nausea symptom of migraine: A post hoc analysis

      HEADACHE
    20. Sheftell, FD; Fox, AW; Weeks, RE; Tepper, SJ
      Differentiating the efficacy of 5-HT1B/1D agonists

      HEADACHE
    21. Gobel, H; Heinze, A; Heinze-Kuhn, K; Lindner, V
      Efficacy and tolerability of rizatriptan 10 mg in migraine: Experience with 70527 patient episodes

      HEADACHE
    22. Pascual, J; Falk, R; Docekal, R; Prusinski, A; Jelencsik, J; Cabarrocas, X; Segarra, X; Luria, X; Ferrer, P
      Tolerability and efficacy of almotriptan in the long-term treatment of migraine

      EUROPEAN NEUROLOGY
    23. Pascual, J; Bussone, G; Hernandez, JF; Allen, C; Vrijens, F; Patel, K
      Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

      EUROPEAN NEUROLOGY
    24. Worthington, I
      Delivery systems for acute migraine medications

      CANADIAN FAMILY PHYSICIAN
    25. Williamson, DJ; Hill, RG; Shepheard, SL; Hargreaves, RJ
      The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs

      BRITISH JOURNAL OF PHARMACOLOGY
    26. Saper, JR
      What matters is not the differences between triptans, but the differences between patients

      ARCHIVES OF NEUROLOGY
    27. Ryan, RE; Diamond, S; Giammarco, RAM; Aurora, SK; Reed, RC; Fletcher, PE
      Efficacy of zolmitriptan at early time-points for the acute treatment of migraine and treatment of recurrence - A randomised, placebo-controlled trial

      CNS DRUGS
    28. Tepper, SJ; Rapoport, AM; Nett, RB
      Eletriptan's clinical claims questioned

      FORMULARY
    29. Dasbach, EJ; Carides, GW; Gerth, WC; Santanello, NC; Pigeon, JG; Kramer, MS
      Work and productivity loss in the rizatriptan multiple attack study

      CEPHALALGIA
    30. Klapper, JA; O'Connor, S
      Rizatriptan wafer-sublingual vs. placebo at the onset of acute migraine

      CEPHALALGIA
    31. Pascual, J; Vega, P; Diener, HC; Allen, C; Vrijens, F; Patel, K
      Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine

      CEPHALALGIA
    32. Tfelt-Hansen, P
      A comment on time-to-event analysis for headache relief

      CEPHALALGIA
    33. Sheftell, FD; Fox, AW
      Acute migraine treatment outcome measures: a clinician's view

      CEPHALALGIA
    34. Salonen, R
      Drug comparisons: why are they so difficult?

      CEPHALALGIA
    35. Gawel, M; Wiebe, S
      Evidence-based analysis of a migraine treatment drug comparison trial

      CEPHALALGIA
    36. Longmore, J; Maguire, JJ; MacLeod, A; Street, L; Schofield, WN; Hill, RG
      Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptoragonist L-775,606 with the mixed 5-HT1B/(1D)-receptor agonist sumatriptan and 5-HT in human isolated coronary artery

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    37. Biddle, AK; Shih, YCT; Kwong, WJ
      Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine

      PHARMACOTHERAPY
    38. Deleu, D; Hanssens, Y
      Current and emerging second-generation triptans in acute migraine therapy:A comparative review

      JOURNAL OF CLINICAL PHARMACOLOGY
    39. Bulger, PG; Cottrell, IF; Cowden, CJ; Davies, AJ; Dolling, UH
      An investigation into the alkylation of 1,2,4-triazole

      TETRAHEDRON LETTERS
    40. Lipton, RB
      Methodologic issues in acute migraine clinical trials

      NEUROLOGY
    41. Solomon, GD; Santanello, N
      Impact of migraine and migraine therapy on productivity and quality of life

      NEUROLOGY
    42. Mathew, NT; Kailasam, J; Gentry, P; Chernyshev, O
      Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trial

      HEADACHE
    43. Adelman, JU; Mannix, LK; Von Seggern, RL
      Rizatriptan tablet versus wafer: Patient preference

      HEADACHE
    44. Sheftell, F; O'Quinn, S; Watson, C; Pait, D; Winter, P
      Low migraine headache recurrence with naratriptan: Clinical parameters related to recurrence

      HEADACHE
    45. Izquierdo, AY
      Treatment of headache

      REVISTA CLINICA ESPANOLA
    46. Peatfield, RC
      Migraine: which triptan?

      HOSPITAL MEDICINE
    47. Tepper, SJ; Rapoport, AM
      The triptans - A summary

      CNS DRUGS
    48. Smith, MA; Ross, MB
      Oral 5-HT1 receptor agonists for migraine: Comparative considerations

      FORMULARY
    49. Dulli, DA
      Naratriptan: An alternative for migraine

      ANNALS OF PHARMACOTHERAPY
    50. van Haarst, AD; van Gerven, JMA; Cohen, AF; De Smet, M; Sterrett, A; Birk, KL; Fisher, AL; De Puy, ME; Goldberg, MR; Musson, DG
      The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    51. Lee, Y; Conroy, JA; Stepanavage, ME; Mendel, CM; Somers, G; McLoughlin, DA; Olah, TV; De Smet, M; Keymeulen, B; Rogers, JD
      Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    52. Deleu, D; Hanssens, Y
      Profiles of 5-HT1B/1D agonists in acute migraine with special reference tosecond generation agents

      ACTA NEUROLOGICA BELGICA
    53. Dahlof, CGH; Rapoport, AM; Sheftell, FD; Lines, CR
      Rizatriptan in the treatment of migraine

      CLINICAL THERAPEUTICS
    54. van Niel, MB; Collins, I; Beer, MS; Broughton, HB; Cheng, SKF; Goodacre, SC; Heald, A; Locker, KL; MacLeod, AM; Morrison, D; Moyes, CR; O'Connor, D; Pike, A; Rowley, M; Russell, MGN; Moyes, CR; O'Connor, D; Pike, A; Rowley, M; Russell, MGN; Sohal, B; Stanton, JA; Thomas, S; Verrier, H; Watt, AP; Castro, JL
      Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles

      JOURNAL OF MEDICINAL CHEMISTRY
    55. Goadsby, PJ
      Understanding migraine pathophysiology through studying the mechanism of action of rizatriptan

      HEADACHE
    56. Lipton, RB
      Pharmacologic profile and clinical efficacy of rizatriptan

      HEADACHE
    57. Dahlof, C
      Safety and tolerability of the novel 5-HT1B/1D agonist rizatriptan in migraineurs

      HEADACHE
    58. Bomhof, M; Paz, J; Legg, N; Allen, C; Vandormael, K; Patel, K
      Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine

      EUROPEAN NEUROLOGY
    59. Dooley, M; Faulds, D
      Rizatriptan - A review of its efficacy in the management of migraine

      DRUGS
    60. Cumberbatch, MJ; Williamson, DJ; Mason, GS; Hill, RG; Hargreaves, RJ
      Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist

      BRITISH JOURNAL OF PHARMACOLOGY
    61. DAHLOF CGH; MATHEW N
      CARDIOVASCULAR SAFETY OF 5HT(1B 1D) AGONISTS - IS THERE A CAUSE FOR CONCERN/

      Cephalalgia
    62. Cumberbatch, MJ; Hill, RG; Hargreaves, RJ
      Differential effects of the 5HT(1B/1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses

      CEPHALALGIA
    63. Lee, Y; Ermlich, SJ; Sterrett, AT; Goldberg, MR; Blum, RA; Brucker, MJ; McLoughlin, DA; Olah, TV; Zhao, J; Rogers, JD
      Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females

      BIOPHARMACEUTICS & DRUG DISPOSITION
    64. TEALL J; TUCHMAN M; CUTLER N; GROSS M; WILLOUGHBY E; SMITH B; JIANG K; REINES S; BLOCK G
      RIZATRIPTAN (MAXALT) FOR THE ACUTE TREATMENT OF MIGRAINE AND MIGRAINERECURRENCE - A PLACEBO-CONTROLLED, OUTPATIENT STUDY

      Headache
    65. Goldstein, J; Ryan, R; Jiang, KH; Getson, A; Norman, B; Block, GA; Lines, C
      Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine

      HEADACHE
    66. Tfelt-Hansen, P; Teall, J; Rodriguez, F; Giacovazzo, M; Paz, J; Malbecq, W; Block, GA; Reines, SA; Visser, WH
      Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine

      HEADACHE
    67. Block, GA; Goldstein, J; Polis, A; Reines, SA; Smith, ME
      Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine

      HEADACHE
    68. PAGNIEZ F; VALENTIN JP; VIEU S; COLPAERT FC; JOHN GW
      PHARMACOLOGICAL ANALYSIS OF THE HEMODYNAMIC-EFFECTS OF 5-HT1B D RECEPTOR AGONISTS IN THE NORMOTENSIVE RAT/

      British Journal of Pharmacology
    69. SANTANELLO NC; POLIS AB; HARTMAIER SL; KRAMER MS; BLOCK GA; SILBERSTEIN SD
      IMPROVEMENT IN MIGRAINE-SPECIFIC QUALITY-OF-LIFE IN A CLINICAL-TRIAL OF RIZATRIPTAN

      Cephalalgia
    70. GIJSMAN H; KRAMER MS; SARGENT J; TUCHMAN M; MATZURAWOLFE D; POLIS A; TEALL J; BLOCK G; FERRARI MD
      DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY OF RIZATRIPTAN (MK-462) IN THE ACUTE TREATMENT OF MIGRAINE

      Cephalalgia
    71. SCIBERRAS DG; POLVINO WJ; GERTZ BJ; CHENG HY; STEPANAVAGE M; WITTREICH J; OLAH T; EDWARDS M; MANT T
      INITIAL HUMAN-EXPERIENCE WITH MK-462 (RIZATRIPTAN) - A NOVEL 5-HT1D AGONIST

      British journal of clinical pharmacology
    72. CUMBERBATCH MJ; HILL RG; HARGREAVES RJ
      RIZATRIPTAN HAS CENTRAL ANTINOCICEPTIVE EFFECTS AGAINST DURALLY EVOKED-RESPONSES

      European journal of pharmacology
    73. WILLIAMSON DJ; SHEPHEARD SL; HILL RG; HARGREAVES RJ
      THE NOVEL ANTIMIGRAINE AGENT RIZATRIPTAN INHIBITS NEUROGENIC DURAL VASODILATION AND EXTRAVASATION

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 09:21:34